AUSTIN, TX (January 14, 2025)—Prodigy Health is delighted to announce Newton Juhng’s appointment to its Board of Directors. A seasoned finance professional with extensive experience in healthcare investments and corporate lending, Mr. Juhng currently serves as Managing Director and Head of Healthcare at A-CAP Management. He focuses on private credit investments in this role, including leveraged finance transactions and direct lending to healthcare companies.
Throughout his career in leveraged finance, Mr. Juhng has held key positions, such as Managing Director at Capital One Healthcare and Senior Vice President at GE Capital’s Healthcare Financial Services unit. Before his roles in corporate lending, he spent over a decade as a senior equity analyst covering the healthcare services industry at esteemed firms such as FBR Capital Markets, BB&T Capital Markets, Piper Jaffray, SunTrust Robinson Humphrey, and Dresdner Kleinwort Wasserstein.
Mr. Juhng earned a Bachelor of Arts in Psychology from Amherst College and completed graduate-level coursework at Georgetown University, focusing on human physiology and biophysics. Early in his career, he conducted groundbreaking basic science and clinical research on epilepsy and other neuroimmunology disorders during a three-year tenure at the National Institutes of Health in Bethesda, Maryland.
An active community member, Mr. Juhng serves on the Board of Directors for three other healthcare companies and Tenafly Youth Basketball. Since 2014, he has supported various local initiatives and serves on the elder board of Metro Community Church.
“Newton’s extensive success in the financial sector, specifically in healthcare perfectly complements our expertise in specialty pharmaceutical distribution,” said the Jeff Morris, CFO. “By combining his finance acumen with our commitment to data-driven solutions and genuine care, we look forward to expanding our reach in meeting the evolving needs of patients and partners everywhere.”